Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

SeaDragon shareholders back $4M injection

By Rebecca Howard

May 17 (BusinessDesk) - SeaDragon has managed to stave off possible receivership or liquidation after shareholders backed resolutions to allow a $4 million cash injection.

"Management’s current estimates have SeaDragon unlikely to pay its debts as they fall due sometime during July this year unless a capital injection is provided," the company said in the notice of today's special meeting. In that event, the "directors will have no option but to place the company into receivership or liquidation."

The interdependent resolutions were related to cornerstone shareholder Pescado - largely owned by SeaDragon director Mark Stewart - agreeing to provide $4 million via a convertible loan note with a number of conditions, one of which requires the existing convertible noteholders, including Pescado, to forgo interest.

Chair Bryan Mogridge said the action saves the company approximately $1 million over the next year and coupled with the $4 million of convertible loan note effectively provides $5 million over the next 12 months should the full amount be required.

He said the funds were necessary because the company hasn't performed to expectations. "Despite revenue being some 50 percent higher than the previous year we anticipate a loss of around $6.6 million after tax from operations, being provisionally recorded." It flagged the loss earlier this year.

The cash injection should be sufficient to see the company through April/May 2020, he said.

Mogridge said it is highly likely that the new notes will convert to equity on March 31, 2021.

With the existing convertible notes held by Comvita, Pescado and BioScience converting in March 2020, and assuming the options held by Comvita are not exercised and that no further equity is issued, Stewart's Pescado will end up owning 39.44 percent of SeaDragon, BioScience will hold 17.18 percent, Comvita 13.79 and other shareholders will collectively own 29.69 percent, he said.

According to Mogridge, the company's plan to shift up the value chain to Omega 3 markets is still valid, but the time to achieve an acceptable profit will be longer than first thought.

"Our goal for management is to endeavour to make this injection last much longer and maybe take the company to a position of cash independence. We will update the market on this as required," he said.

SeaDragon shares last traded at 0.2 cents and are down 33 percent so far this year. That values the company at about $9.7 million.


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Primary Sector Council Report: Vision To Unite The Primary Sector Launched

Agriculture Minister Damien O’Connor has welcomed the release of a bold new vision for the country’s vital food and fibre sector. More>>

ALSO:

Crown Accounts: Treasury HYEFU Sees Deficit Then Rising Surpluses

An operating balance before gains and losses deficit of $0.9 billion is forecast in the current year, before returning to a small surplus in 2020/21 which then grows to reach $5.9 billion (1.5% of GDP) in 2023/24. More>>

ALSO:

Fuels Rushing In: Govt "Ready To Act" On Petrol Market Report

The Government will now take the Commerce Commission’s recommendations to Cabinet...
• A more transparent wholesale pricing regime • Greater contractual freedoms and fairer terms • Introducing an enforceable industry code of conduct • Improve transparency of premium grade fuel pricing... More>>

ALSO:

Reserve Bank Capital Review Decision: Increased Bank Capital Requirements

Governor Adrian Orr said the decisions to increase capital requirements are about making the banking system safer for all New Zealanders, and will ensure bank owners have a meaningful stake in their businesses. More>>

ALSO: